JETRO Startup
Global Startup Acceleration Program (GSAP) Alumnis実写 版 ブラック ジャックnc.
CIC '22 Bio/Healthcare
Healthcare Biotech
実写 版 ブラック ジャックs a privately owned preclinical stage start-up biotech developing oligonucleotide aptamer-based pharmaceuticals and medical devices. Our mission is to provide novel therapies using DNA aptamer discovery platform, Xenoligo beneficial for patients. TAGCyx can create innovative aptamers with high affinity and specificity for target molecules using our proprietary technology, artificial nucleic acid base and mini-hairpin stabilization structure.
Profile
- Year founded
- 22-Mar-07
- Name of the representative
- Chizuko Koseki / President & CEO
- HQ location(City)
- Tokyo
- Total amount raised to date
- JPY1,800,000(as of Dec.2022) (Unit:JPY thousand, USD mio)
- Stage
- Series C
- Major investors/VCs
- Partnership
- CAGE Bio Inc., Otsuka Chemical Co., Ltd., SBI Pharmaceuticals Co., Ltd., Resonac corporation,GC Pharma corp.
- Major Clients
CEO/Team
*The contents of this page are subject to change without prior notice. Please contact us for the latest information.